Thymic stromal lymphopoietin is a key mediator of breast cancer progression.

Thymic stromal lymphopoietin is a key mediator of breast cancer progression.
复制标题

DOI:
10.4049/jimmunol.1100463
复制
发表时间:
2011-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Biragyn A
Biragyn A
中科院分区:
其他
文献类型:
--
作者:
Olkhanud PB;Rochman Y;Bodogai M;Malchinkhuu E;Wejksza K;Xu M;Gress RE;Hesdorffer C;Leonard WJ;Biragyn A

文献摘要

参考文献

被引文献

相似文献

炎症是一把双刃剑,可以促进或抑制癌症进展。在这里,我们报告说,胸腺基质淋巴细胞生成素(TSLP),IL-7样1型炎性细胞因子,往往与诱导Th 2型过敏反应在肺部,也表达在人类和小鼠的癌症。我们对小鼠癌细胞的研究表明,TSLP在癌症逃逸中起着重要作用,因为它在癌细胞中的失活足以几乎完全消除癌症进展和肺转移。TSLP的促癌活性主要需要通过CD 4 + T细胞上的TSLP受体进行信号传导,促进Th 2偏斜的免疫应答和免疫抑制因子如IL-10和IL-13的产生。因此,TSLP的表达可能是一个有用的预后标志物,其靶向可能具有治疗潜力。
Inflammation is a double-edged sword that can promote or suppress cancer progression. Here we report that thymic stromal lymphopoietin (TSLP), an IL-7-like type 1 inflammatory cytokine that is often associated with the induction of Th2-type allergic responses in the lungs, is also expressed in human and murine cancers. Our studies with murine cancer cells indicate that TSLP plays an essential role in cancer escape, as its inactivation in cancer cells alone was sufficient to almost completely abrogate cancer progression and lung metastasis. The cancer-promoting activity of TSLP primarily required signaling through the TSLP receptor on CD4+ T cells, promoting Th2-skewed immune responses and production of immunosuppressive factors such as IL-10 and IL-13. Expression of TSLP therefore may be a useful prognostic marker and its targeting could have therapeutic potential.
DOI: 10.1158/0008-5472.can-08-4619
发表时间: 2009-07-15
期刊: Cancer research
影响因子: 11.2
作者:
Olkhanud PB;Baatar D;Bodogai M;Hakim F;Gress R;Anderson RL;Deng J;Xu M;Briest S;Biragyn A
通讯作者: Biragyn A
DOI: 10.1084/jem.20062211
发表时间: 2007-02-19
期刊: The Journal of experimental medicine
影响因子: --
作者:
Allakhverdi Z;Comeau MR;Jessup HK;Yoon BR;Brewer A;Chartier S;Paquette N;Ziegler SF;Sarfati M;Delespesse G
通讯作者: Delespesse G
DOI: 10.1084/jem.194.6.847
发表时间: 2001-09-17
期刊: The Journal of experimental medicine
影响因子: --
作者:
Iellem A;Mariani M;Lang R;Recalde H;Panina-Bordignon P;Sinigaglia F;D'Ambrosio D
通讯作者: D'Ambrosio D
DOI: 10.1182/blood-2008-02-137414
发表时间: 2008-10-15
期刊: BLOOD
影响因子: 20.3
作者:
Mazzucchelli, Renata;Hixon, Julie A.;Durum, Scott K.
通讯作者: Durum, Scott K.
DOI: 10.1111/j.1365-2613.2007.00539.x
发表时间: 2007-10-01
影响因子: 3
作者:
DuPre, Sally A.;Redelman, Doug;Hunter, Kenneth W., Jr.
通讯作者: Hunter, Kenneth W., Jr.